SEC EDGAR Filing Information

Form 10QSB -- Optional form for quarterly and transition reports of small business issuers

Period of Report: 2007-06-30
Filing Date Changed: 2007-08-14
Documents: 6

SEC Accession No.
0000812796-07-000070
Filing date: 2007-08-15
Accepted: 2007-08-14 19:30:44

Table of submitted documents:

Seq	Type	Document	Size	Description
1	10QSB	dor10q2q2007.htm	445490	10 QSB FOR 2Q 2007
2	EX-31.1	ceocert2q2007.htm	9716	CEO CERT 2Q 2007
3	EX-31.2	cfocert2q2007.htm	9724	CFO CERT 2Q 2007
4	EX-32.1	ceo9062q2007.htm	5043	CEO 906 SOX 2Q 2007
5	EX-32.2	cfo9062q2007.htm	4906	CFO 906 SOX 2Q 2007
6	EX-99.1	riskfactors022007.htm	71470	RISK FACTORS 2Q 2007

		0000812796-07-000070.txt	547966	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Filer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10QSB | Act: 34 | File No.: 000-16929 | Film No.: 071057673
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
1101 BRICKELL AVENUE
SUITE 701 S
MIAMI FL 33131
305-534-3383

Mailing Address
1101 BRICKELL AVENUE
SUITE 701 S
MIAMI FL 33131